BeiGene to Host Investor Conference Call and Webcast to Discuss Clinical Study Results Presented at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program

NEXT STORY
Chembio Diagnostics to Participate in Upcoming Investor Conferences
PREV STORY
Precision BioSciences to Present at Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche’s Actemra/RoActemra becomes the first biologic therapy approved by the FDA for slowing the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease, a rare, debilitating condition

author_avatar
NASDAQ Market News

TRIO Enrolls First Patient Into PHASE III NATALEE Clinical Trial

Timely Enrollment Signifies Milestone in TRIOEDMONTON, Alberta, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Translational ...

author_avatar
NASDAQ Market News

FDA grants Breakthrough Device Designation for Roche’s Elecsys Growth Differentiation Factor-15 (GDF-15) assay to help identify patients suitable for innovative treatment addressing unintentional weight loss in cancer patients

author_avatar
NASDAQ Market News